Tower Research Capital LLC (TRC)

Position in NXL — Nexalin Technology, Inc.

CIK 1533421 NEW YORK, NY

Position in NXL

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$696

-$38 QoQ

Shares Held

0.0% QoQ

Ownership

0.010%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#14

of 20 holders

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Tower Research Capital LLC (TRC) holds $34,014,339 across 122 Medical Devices names. NXL ranks #117 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	SNN	Smith & Nephew PLC	301,051	$8,673,279
2	PHG	Koninklijke Philips NV	172,778	$4,697,833
3	BSX	Boston Scientific Corp	86,205	$3,679,229
4	ABT	Abbott Laboratories	28,491	$2,585,273
5	MDT	Medtronic plc	31,327	$2,450,710
6	SYK	Stryker Corp	5,175	$1,629,296
7	PEN	Penumbra Inc	3,046	$961,774
8	EW	Edwards Lifesciences Corp	9,286	$840,010

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$696	2,111	-0.0%	Shares	Defined	2026-08-11
2026-03-31	$734	2,112	-9.7%	Shares	Defined	2026-05-15
2025-12-31	$1,304	2,338	+63.4%	Shares	Defined	2026-02-17
2025-09-30	$43	1,431	-81.0%	Shares	Defined	2025-11-14
2025-06-30	$247	7,522	+361.2%	Shares	Defined	2025-08-15
2025-03-31	$106	1,631	-75.2%	Shares	Defined	2025-05-15
2024-09-30	$146	6,573	-33.4%	Shares	Defined	2024-11-14
2024-06-30	$556	9,870	+8.7%	Shares	Defined	2024-08-13
2024-03-31	$423	9,079	+0.1%	Shares	Defined	2024-05-15
2023-12-31	$122	9,071	+0.1%	Shares	Defined	2024-02-13
2023-09-30	$132	9,066	+0.0%	Shares	Defined	2023-11-14
2023-06-30	$269	9,062	-0.1%	Shares	Defined	2023-08-14
2023-03-31	$7	9,068	+9.9%	Shares	Defined	2023-05-09
2022-12-31	$6	8,254	—	Shares	Defined	2023-02-10
No filing history on record for this holder in this stock.